Complete Resolution of a Large Bicuspid Aortic Valve Thrombus with Anticoagulation in Primary Antiphospholipid Syndrome

被引:9
作者
Rachwan, Rayan Jo [1 ]
Daher, Ghassan E. [2 ]
Fares, Jawad [3 ]
Rachoin, Rachoin [4 ]
机构
[1] Indiana Univ Sch Med, Dept Med, Indianapolis, IN 46202 USA
[2] St Louis Univ, Sch Med, Dept Internal Med, St Louis, MO USA
[3] Amer Univ Beirut, Fac Med, Beirut, Lebanon
[4] Notre Dame des Secours Univ Hosp, Div Cardiovasc Med, Byblos, Lebanon
关键词
antiphospholipid syndrome; aortic valve; thrombosis; anticoagulation; echocardiography; LIBMAN-SACKS ENDOCARDITIS; ANTICARDIOLIPIN ANTIBODIES; RECURRENT THROMBOSIS; DUKE CRITERIA; LONG-TERM; FOLLOW-UP; ASSOCIATION; PREVENTION; PREVALENCE; WARFARIN;
D O I
10.3389/fcvm.2017.00059
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Native aortic valve thrombosis in primary antiphospholipid syndrome (APLS) is a rare entity. We describe a 38-year-old man who presented with neurological symptoms and a cardiac murmur. Transthoracic echocardiography detected a large bicuspid aortic valve thrombus. Laboratory evaluation showed the presence of antiphospholipid antibodies. Anticoagulation was started, and serial echocardiographic studies showed complete resolution of the aortic valve vegetation after 4 months. The patient improved clinically and had no residual symptoms. This report and review of the literature suggests that vegetations in APLS can be treated successfully with conservative treatment, regardless of their size.
引用
收藏
页数:5
相关论文
共 33 条
[1]   Resolution of vegetations with anticoagulation after myocardial infarction in primary antiphospholipid syndrome [J].
Agirbasli, MA ;
Hansen, DE ;
Byrd, BF .
JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY, 1997, 10 (08) :877-880
[2]   The geoepidemiology of the antiphospholipid antibody syndrome [J].
Biggioggero, Martina ;
Meroni, Pier Luigi .
AUTOIMMUNITY REVIEWS, 2010, 9 (05) :A299-A304
[3]   HIGH PREVALENCE OF SIGNIFICANT HEART-VALVE LESIONS IN PATIENTS WITH THE PRIMARY ANTIPHOSPHOLIPID SYNDROME [J].
CERVERA, R ;
KHAMASHTA, MA ;
FONT, J ;
REYES, PA ;
VIANNA, JL ;
LOPEZSOTO, A ;
AMIGO, MC ;
ASHERSON, RA ;
AZQUETA, M ;
PARE, C ;
VARGAS, J ;
ROMERO, A ;
INGELMO, M ;
HUGHES, GRV .
LUPUS, 1991, 1 (01) :43-47
[4]   The Euro-Phospholipid project: epidemiology of the antiphospholipid syndrome in Europe [J].
Cervera, R. ;
Boffa, M-C ;
Khamashta, M. A. ;
Hughes, G. R. V. .
LUPUS, 2009, 18 (10) :889-893
[5]   A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndrome [J].
Crowther, MA ;
Ginsberg, JS ;
Julian, J ;
Denburg, J ;
Hirsh, J ;
Douketis, J ;
Laskin, C ;
Fortin, P ;
Anderson, D ;
Kearon, C ;
Clarke, A ;
Geerts, W ;
Forgie, M ;
Green, D ;
Costantini, L ;
Yacura, W ;
Wilson, S ;
Gent, M ;
Kovacs, MJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (12) :1133-1138
[6]   PATIENTS WITH ANTIPHOSPHOLIPID ANTIBODIES AND VENOUS THROMBOSIS SHOULD RECEIVE LONG-TERM ANTICOAGULANT TREATMENT [J].
DERKSEN, RHWM ;
DEGROOT, PG ;
KATER, L ;
NIEUWENHUIS, HK .
ANNALS OF THE RHEUMATIC DISEASES, 1993, 52 (09) :689-692
[7]   Negative predictive value of the Duke criteria for infective endocarditis [J].
Dodds, GA ;
Sexton, DJ ;
Durack, DT ;
Bashore, TM ;
Corey, GR ;
Kisslo, J .
AMERICAN JOURNAL OF CARDIOLOGY, 1996, 77 (05) :403-407
[8]   Echocardiographic evaluation of patients with primary antiphospholipid syndrome [J].
Espínola-Zavaleta, N ;
Vargas-Barrón, J ;
Colmenares-Galvis, T ;
Cruz-Cruz, F ;
Romero-Cárdenas, A ;
Keirns, C ;
Amigo, MC .
AMERICAN HEART JOURNAL, 1999, 137 (05) :973-978
[9]  
Farrell S, 2010, J SURG CASE REP, V2010, P1, DOI [10.1093/jscr/2010.6.1, DOI 10.1093/JSCR/2010.6.1]
[10]   A randomized clinical trial of high-intensity warfarin vs. conventional antithrombotic therapy for the prevention of recurrent thrombosis in patients with the antiphospholipid syndrome(WAPS) [J].
Finazzi, G ;
Marchioli, R ;
Brancaccio, V ;
Schinco, P ;
Wisloff, F ;
Musial, J ;
Baudo, F ;
Berrettini, M ;
Testa, S ;
D'Angelo, A ;
Tognoni, G ;
Barbui, T .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2005, 3 (05) :848-853